WCG
CALC icon

Weaver Consulting Group’s CalciMedica CALC Stock Holding History

Weaver Consulting Group’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,393
Closed -$21.4K – 266
2025
Q2 		$21.4K Buy
+13,393
New +$23K 0.01% 245

Other funds holding CALC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return
SSIM
Sheets Smith Investment Management Houston, Texas $154M AUM 66.97% 1-Year Est. Return

Weaver Consulting Group's CALC Position: Q3 2025 in Review

Weaver Consulting Group sold out of CalciMedica (CALC) in Q3 2025, closing a stake of 13,393 shares — an estimated $21.4K sold.

Weaver Consulting Group first reported a position in CALC in Q2 2025 and held it in 1 quarter. The position peaked at $21.4K in Q2 2025. 31 funds tracked by Wall St. Rank hold CALC as of Q3 2025.

  • Weaver Consulting Group reported no remaining CalciMedica position as of Q3 2025 after selling out during the quarter.
  • Weaver Consulting Group sold 13,393 CalciMedica shares in Q3 2025, an estimated $21.4K.
  • Weaver Consulting Group first reported a position in CalciMedica in Q2 2025 and held it in 1 quarter.
  • Weaver Consulting Group's CalciMedica position peaked at $21.4K in Q2 2025.
  • 31 funds tracked by Wall St. Rank held CalciMedica as of Q3 2025.

Based on Weaver Consulting Group's 13F filing for Q3 2025, filed 12 Nov 2025.